The Future of Accelerated Approval: Evolving to Better Serve Cancer Patients



Tracy Baroni-Allmon, BS Pharm, JD
Head, Global Oncology Access &
Reimbursement Policy
Andrea Ferris, MBA
President and Chief Executive Officer
LUNGevity Foundation
Ryan Hohma, JD
Vice President - Public Affairs
Friends of Cancer Research
Paul Jeffrey, PharmD
Jeff℞ey Consulting
Retired, Sr. Director of Pharmacy
Robert Orlowski, MD, PhD
Chairman, Ad Interim, Director of Myeloma and Professor of Medicine
Department of Lymphoma/Myeloma and
Experimental Therapeutics
Division of Cancer Medicine
MD Anderson Cancer Center
Andrew Robertson, PhD, JD
VP, Head of Global Regulatory Policy and Innovation
Nicholas J. Sarlis, MD, PhD, FACP
Head of Medical Content
Amplity Health

Live webinar occurred on June 28th, 2:00 – 3:00 pm ET.

This recording is provided by Takeda Oncology.

Designed to foster a conversation on exploring opportunities to sustain early approval and access to treatments for patients with serious and life-threatening conditions, this webinar includes the following topics:

  • An overview of accelerated approval and its use in oncology
  • The impact of the approval process on patients and physicians
  • A discussion of how to evolve the process to meet patients’ needs
  • Identification of policy action that could benefit the cancer community

Related Articles